Arthritis Pain Relief

Posts Tagged ‘International Ltd’

U-M researchers receive largest single collection of psoriasis DNA samples
( University of Michigan Health System ) Millions of Americans struggling with psoriasis and psoriatic arthritis are one step closer to a cure with the release of the first National Psoriasis Victor Henschel BioBank DNA samples for use in research at the University of Michigan Health System; research that hopes to uncover the unknowns about the genetics of psoriasis and psoriatic arthritis.
Read more on EurekAlert!

HEALTHWISE:Education needed about psoriasis, its effects
August was National Psoriasis Awareness Month, and according to the National Psoriasis Foundation, psoriasis is the most common autoimmune disease in the United States, affecting as many as 7.5 million Americans.
Read more on MyCentralJersey.com

Chelsea Therapeutics Announces FDA Approval of CH-4051 Phase II Protocol
CHARLOTTE, N.C. — Chelsea Therapeutics International, Ltd. announced confirmation by the U.S. Food and Drug Administration that its proposed Phase II protocol for CH-4051 in rheumatoid arthritis has been approved by the agency.
Read more on GlobeNewswire via Yahoo! Finance

Bookmark It

Hide Sites

Health notes
Times staff Tuesday, August 31, 2010 Health notes No-cost amplified phones available The Deaf and Hearing Connection recently announced the availability of no-cost amplified telephones at the Aging Well Center in the Long Center at 1501 N Belcher Road, Clearwater. The Deaf and Hearing Connection offers amplified telephones and related equipment at no cost to permanent Florida residents who are …
Read more on St. Petersburg Times

FDA Warning Letter to DePuy RE: TruMatch™ Personalized Solutions System and Corail® Hip System
DePuy Orghopaedics, a division of Johnson & Johnson, received a warning letter from the FDA Department of Health and Human Services on August 19th, 2010. The letter is in regard to unauthorized marketing of the TruMatch™ Personalized Solutions System and the Corail® Hip System.
Read more on US Recall News

Cryo-Save to conduct public awareness on cord blood stem cell
Cryo-Save, Europe’s leading stem cell bank has announced that September would be their cord blood stem cell awareness month in India.
Read more on PharmaBiz

Chelsea gets US FDA approval to begin rheumatoid arthritis drug phase II trial
Chelsea Therapeutics International, Ltd. announced confirmation by the US Food and Drug Administration (FDA) that its proposed phase II protocol for CH-4051 in rheumatoid arthritis has been approved by the agency.
Read more on PharmaBiz

Bookmark It

Hide Sites

Gaming Veteran Greg Liggett Promoted to Casino Manager at Barona Resort & Casino
SAN DIEGO, CA–(Marketwire – August 26, 2010) – Barona Resort & Casino announced today that Greg Liggett has been promoted to casino manager. A gaming industry veteran of more than 33 years, Liggett’s past work experience has included executive management positions at casinos across the nation. Most recently Barona’s director of special events and promotions, Liggett is now one of eight casino …
Read more on Marketwire

Chelsea Therapeutics gets FDA OK to start study
(AP:CHARLOTTE, N.C.) Chelsea Therapeutics International Ltd. said Thursday it received Food and Drug Administration clearance to start a midstage study on a potential rheumatoid arthritis drug.
Read more on INO News

Bookmark It

Hide Sites